Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV single-arm multicenter study of Jiuweixifeng particle for children with tic disorder
ChiCTR-ONC-13003787Phase 4Recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Feb 2014
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Jiuwei Xifeng Granules in tic disorder, sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Curative efficacy rate, YGTSS total score and 5 more. Started Feb 2014; status: recruiting.
02
Drugs
Jiuwei Xifeng Granules
03
Conditions
tic disorder
Beyond the preview
Go deeper on ChiCTR-ONC-13003787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003787.